Rinella ME, Lieu HD, Kowdley KV, Goodman ZD, et al. A randomized, double-blind, placebo-controlled trial of Aldafermin in patients with nonalcoholic steatohepatitis and compensated cirrhosis. Hepatology 2023 Sep 21. doi: 10.1097/HEP.0000000000000607.
PMID: 37732990